Development of a thermostable microneedle patch for influenza vaccination

Journal of Pharmaceutical Sciences

Volumn 104, Issue 2, 2015, Pages 740-749

  Mistilis, Matthew J ^a   Bommarius, Andreas S ^a   Prausnitz, Mark R ^a  

^a Georgia Institute of Technology   (United States)

Author keywords

Drug delivery systems; Drying; Excipients; Formulation; Protein delivery; Protein formulation; Stability; Vaccines

Indexed keywords

4 (2 HYDROXYETHYL) 1 PIPERAZINEETHANESULFONIC ACID; AMINO ACID; DIMETICONE; INFLUENZA VACCINE; POLYSACCHARIDE;

ARTICLE; DRUG FORMULATION; DRUG PACKAGING; DRUG STABILITY; DRUG STORAGE; INFLUENZA VACCINATION; MICRONEEDLE; MICRONEEDLE PATCH; ROOM TEMPERATURE; SEASONAL INFLUENZA; THERMOSTABILITY; CHEMISTRY; HUMAN; MEDICINAL CHEMISTRY; NEEDLE; TRANSDERMAL PATCH; TRENDS; VACCINATION;

CHEMISTRY, PHARMACEUTICAL; DRUG STABILITY; HUMANS; INFLUENZA VACCINES; NEEDLES; TRANSDERMAL PATCH; VACCINATION;

EID: 84922902866     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.24283     Document Type: Article

References (26)

1. World Health Organization Influenza Fact Sheet. Accessed July 1, 2014, at: http://www.who.int/mediacentre/factsheets/fs211/en/index.html.
2. Grohskopf LA, Olsen SJ, Sokolow LZ, Bresee JS, Cox NJ, Broder KR, Karron RA, Walter EB. 2014. Prevention and control of seasonal influenza with vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP) - United States, 2014-15 influenza season. Morb Mortal Wkly Rep 63:691-697.
3. Ghedin E, Sengamalay NA, Shumway M, Zaborsky J, Feldblyum T, Subbu V, Spiro DJ, Sitz J, Koo H, Bolotov P, Dernovoy D, Tatusova T, Bao Y, St George K, Taylor J, Lipman DJ, Fraser CM, Taubenberger JK, Salzberg SL. 2005. Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolution. Nature 437:1162-1166.
4. Santibanez TA, Zhai Y, O'Halloran A, Kahn K, Srivastav A, Lu PJ, Kennedy ED, Bridges CB, Williams WW, Greby SM, Singleton JA. Flu vaccination coverage, United States, 2012-13 influenza season. Accessed July 2014, http://www.cdc.gov/flu/fluvaxview/coverage-1213estimates.htm.
5. Taddio A, Ipp M, Thivakaran S, Jamal A, Parikh C, Smart S, Sovran J, Stephens D, Katz J. 2012. Survey of the prevalence of immunization non-compliance due to needle fears in children and adults. Vaccine 30:4807-4812.
6. Sullivan SP, Koutsonanos DG, Martin MD, Lee JW, Zarnitsyn V, Choi SO, Murthy N, Compans RW, Skountzou I, Prausnitz MR. 2010. Dissolving polymer microneedle patches for influenza vaccination. Nat Med 16:915-920.
7. Kommareddy S, Baudner BC, Oh S, Kwon S-y, Singh M, O'Hagan DT. 2012. Dissolvable microneedle patches for the delivery of cell-culture-derived influenza vaccine antigens. J Pharm Sci 101:1021-1027.
8. Kang SM, Song JM, Kim YC. 2012. Microneedle and mucosal delivery of influenza vaccines. Expert Rev Vaccines 11:547-560.
9. Matsuo K, Hirobe S, Yokota Y, Ayabe Y, Seto M, Quan Y-S, Kamiyama F, Tougan T, Horii T, Mukai Y, Okada N, Nakagawa S. 2012. Transcutaneous immunization using a dissolving microneedle array protects against tetanus, diphtheria, malaria, and influenza. J Control Release 160:495-501.
10. Koutsonanos D, Compans R, Skountzou I. 2013. Targeting the skin for microneedle delivery of influenza vaccine. In Crossroads between innate and adaptive immunity IV; Katsikis PD, Schoenberger SP, Pulendran B, Eds. New York: Springer, pp 121-132.
11. Gill HS, Denson DD, Burris BA, Prausnitz MR. 2008. Effect of microneedle design on pain in human volunteers. Clin J Pain 24:585-594.
12. Norman JJ, Arya JM, McClain MA, Frew PM, Meltzer MI, Prausnitz MR. 2014. Microneedle patches: Usability and acceptability for self-vaccination against influenza. Vaccine 32:1856-1862.
13. Pikal MJ. 2010. Mechanisms of protein stabilization during freeze-drying storage: The relative protection by stabilizing additives. In Freeze-drying/lyophilization of pharmaceutical and biological products; Rey L, May JC, Eds. 3rd ed. CRC Press. Boca Raton, FL, USA.
14. Amorij JP, Huckriede A, Wischut J, Frijlink HW, Hinrichs WLJ. 2008. Development of stable influenza vaccine powder formulations: Challenges and possibilities. Pharm Res 25:1256-1273.
15. Kim YC, Quan FS, Compans RW, Kang SM, Prausnitz MR. 2010. Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity. J Control Release 142:187-195.
16. Chen X, Fernando GJP, Crichton ML, Flaim C, Yukiko SR, Fairmaid EJ, Corbett HJ, Primiero CA, Ansaldo AB, Frazer IH, Brown LE, Kendall MAF. 2011. Improving the reach of vaccines to low-resource regions, with a needle-free vaccine delivery device and long-term ther-mostabilization. J Control Release 152:349-355.
17. Choi HJ, Bondy BJ, Yoo DG, Compans RW, Kang SM, Prausnitz MR. 2013. Stability of whole inactivated influenza virus vaccine during coating onto metal microneedles. J Control Release 166:159-171.
18. Kim YC, Quan FS, Compans RW, Kang SM, Prausnitz MR. 2010. Formulation of microneedles coated with influenza virus-like particle vaccine. AAPS PharmSciTech 11:1193-1201.
19. Nazari M, Kurdi M, Heerklotz H. 2012. Classifying surfactants with respect to their effect on lipid membrane order. Biophys J 102:498-506.
20. Schlehuber LD, McFadyen IJ, Shu Y, Carignan J, Duprex WP, Forsyth WR, Ho JH, Kitsos CM, Lee GY, Levinson DA, Lucier SC, Moore CB, Nguyen NT, Ramos J, Weinstock BA, Zhang J, Monagle JA, Gardner CR, Alvarez JC. 2011. Towards ambient temperature-stable vaccines: The identification of thermally stabilizing liquid formulations for measles virus using an innovative high-throughput infectivity assay. Vaccine 29:5031-5039.
21. Lee JW, Park JH, Prausnitz MR. 2008. Dissolving microneedles for transdermal drug delivery. Biomaterials 29:2113-2124.
22. Williams R, Lyman C. 1932. A neutral buffered standard for hydrogen ion work and accurate titrations which can be prepared in one minute. J Am Chem Soc 54:1911-1912.
23. Williams-Smith DL, Bray RC, Barber MJ, Tsopanakis AD, Vincent SP. 1977. Changes in apparent pH on freezing aqueous buffer solutions and their relevance to biochemical electron-paramagnetic-resonance spectroscopy. Biochem J 167:593-600.
24. Gill HS, Prausnitz MR. 2007. Coating formulations for microneedles. Pharm Res 24:1369-1380.
25. Wolfson LJ, Gasse F, Lee-Martin SP, Lydon P, Magan A, Tibouti A, Johns B, Hutubessy R, Salama P, Okwo-Bele JM. 2008. Estimating the costs of achieving the WHO-UNICEF Global Immunization Vision and Strategy, 2006-2015. Bull World Health Organ 86:27-39.
26. Brandau DT, Jones LS, Wiethoff CM, Rexroad J, Middaugh CR. 2003. Thermal stability of vaccines. J Pharm Sci 92:218-231.